Tempus AI = AI in healthcare Tempus AI is seeking to sell 11 million shares at $35-$37 in its IPO and is slated to begin trading this Friday. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. AI IPOs: few and far between While AI is again the big investment theme of 2024, AI-themed IPOs have been few and far between. But the appetite for AI IPOs is large, and investors are scanning for new investments. Although the anticipated flood of AI IPOs has not yet materialized, Matt Kennedy is confident more are coming.

---

Persons: Matt Kennedy, Howe Ng, Ng, IPOs Organizations: Nasdaq, Astera Labs, Renaissance Capital, Nvidia, Cerebras Systems, Citigroup, Tempus, Forge Global Holdings